Bad Science
Sarepta, eteplirsen: anecdote, data, surrogate outcomes, and the FDA
The Duchenne’s treatment made by Sarepta (eteplirsen) has been in the news this week, as a troubling example of the FDA ...(read more)
by Ben Goldacre
Aggregating the best of the blogs on science and pseudoscience
The Duchenne’s treatment made by Sarepta (eteplirsen) has been in the news this week, as a troubling example of the FDA ...(read more)
by Ben Goldacre
There are recurring howls in my work. One of them is this: in general, if you don’t know which intervention works best, then ...(read more)
by Ben Goldacre
Here’s a useful paper we’ve just published in the BMJ, documenting problems in transparency around approval processes for randomised trials. There’s ...(read more)
by Ben Goldacre
Hi there, I’m doing a few events in Australia and NZ this week: in Sydney, Melbourne, Auckland (only 25 tickets ...(read more)
by Ben Goldacre